Codexis (CDXS) Cash & Equivalents (2010 - 2026)

Codexis' Cash & Equivalents history runs 17 years deep, the most recent figure standing at $36.6 million for Q1 2026.

• In Q1 2026, Cash & Equivalents rose 99.63% year-over-year to $36.6 million; the TTM figure through Mar 2026 stood at $36.6 million (up 99.63% YoY), while the FY2025 annual figure was $50.8 million, up 163.67% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $36.6 million, down from $50.8 million in the prior quarter.
• The five-year high for Cash & Equivalents was $114.0 million in Q4 2022, with the low at $1.6 million in Q3 2024.
• The 5-year median for Cash & Equivalents is $36.6 million (2026), against an average of $48.9 million.
• Peak annual rise in Cash & Equivalents reached 5075.67% in 2022, while the deepest fall reached 98.51% in 2022.
• Codexis' Cash & Equivalents stood at $114.0 million in 2022, then tumbled by 42.87% to $65.1 million in 2023, then slumped by 70.42% to $19.3 million in 2024, then jumped by 163.67% to $50.8 million in 2025, then dropped by 28.0% to $36.6 million in 2026.
• Business Quant data shows CDXS's Cash & Equivalents at $36.6 million in Q1 2026, $50.8 million in Q4 2025, and $25.4 million in Q3 2025.